To test this hypothesis, we used iPSC lines from two kinds of familial ALS: ALS2 and ALS6, carrying ALS2 or FUS mutations, respectively (Shirakawa et al., 2009; Akiyama et al., 2016). The gene discussed is ALS2; the disease is amyotrophic lateral sclerosis.